Cargando…
Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures
Our ability to evaluate outcomes which genuinely reflect patients’ unmet needs, hopes and concerns is of pivotal importance. However, much current clinical research and practice falls short of this objective by selecting outcome measures which do not capture patient value to the fullest. In this Opi...
Autores principales: | Morel, Thomas, Cano, Stefan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667521/ https://www.ncbi.nlm.nih.gov/pubmed/29096663 http://dx.doi.org/10.1186/s13023-017-0718-x |
Ejemplares similares
-
Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients
por: Zanello, Galliano, et al.
Publicado: (2022) -
Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force
por: Nabbout, Rima, et al.
Publicado: (2023) -
The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
por: Southall, Noel T, et al.
Publicado: (2019) -
Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective
por: Austin, Christopher P., et al.
Publicado: (2017) -
Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective
por: Dawkins, Hugh J.S., et al.
Publicado: (2017)